Jianhua Gan Wins SER-CAT Young Investigator Award
Dr. Jianhua Gan, a visiting fellow in the Biomolecular Structure Section, Macromolecular Crystallography Laboratory, has won the 2006 SER-CAT (Southeast Regional Collaborative Access Team) Young Investigator Award. The SER-CAT organization consists of 25 member institutions and was established in 1997 to provide third-generation x-ray capabilities to macromolecular crystallographers and structural biologists in the southeastern region of the United States. The Young Investigator Award, which is designed to recognize the most significant contributions to the scientific program at SER-CAT each year, was presented on March 10 at the annual SER-CAT Symposium in Atlanta. Dr. Gan was recognized for his work on the structural biology of double-stranded RNA processing by ribonuclease III.
INCa-NCI JRPF Program Is Announced
The National Cancer Institute of France (INCa) and NCI have announced a new Joint Research Project Fellowship (JRPF) Program. By training the next generation of cancer researchers together, INCa and NCI aim to foster relationships among cancer researchers in France and the United States. The JRPF Program is open to any aspect of cancer research; however, applications are encouraged for projects involving cancer prevention research, basic research, preclinical/translational research, clinical research, epidemiological research, psychosocial research, behavioral research, and research aimed at improving palliative care and end-of-life care for cancer patients.
It is anticipated that two JRPFs will be awarded in each of the next 3 years. Successful applicants are expected to begin the first leg of the research prior to the end of the current calendar year, will spend 12 to 18 months in each country, and will participate in a joint research project under the mentorship of a French PI and a U.S. PI. Go to http://www.e-cancer.fr and http://www.cancer.gov/oia for more information.
NCI Listens and Learns
Nanotechnology is the creation of microscopic materials used to manipulate matter at an incredibly small scale - between 1 and 100 nanometers, which is about 1/80,000 the width of a human hair. Nanotechnology can be applied in diagnostic imaging by designing injectable, targeted contrast agents that can improve the resolution of cancer imaging to the level of a single cell. Nanotechnology research can be applied to design devices that can be customized to optimally deliver medications for treating conditions, including pain and nausea, and those that can more effectively kill cancer cells.
These are just two examples of how NCI is working to harness the power of nanotechnology to radically change the way cancer is diagnosed, treated, and prevented.
NCI would like feedback from the advocacy community and the public on the following:
- Are cancer patients and others aware that nanotechnology is being used in cancer research?
- Do cancer patients and others think nanotechnology is important for cancer research?
Go to http://ncilistens.cancer.gov to register and post your comments.